These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10768512)

  • 21. In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
    Chen SC; Biswas C; Bartley R; Widmer F; Pantarat N; Obando D; Djordjevic JT; Ellis DH; Jolliffe KA; Sorrell TC
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3233-40. PubMed ID: 20530227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
    Tapia C; León E; Palavecino E
    Rev Med Chil; 2003 Mar; 131(3):299-302. PubMed ID: 12790079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates.
    te Dorsthorst DT; Verweij PE; Meis JF; Mouton JW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3341-6. PubMed ID: 16048945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
    Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
    Espinel-Ingroff A
    J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
    J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of phenylmercuric acetate against ocular pathogenic fungi.
    Xu Y; Zhao D; Gao C; Zhou L; Pang G; Sun S
    J Antimicrob Chemother; 2012 Aug; 67(8):1941-4. PubMed ID: 22514262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B.
    Gottfredsson M; Jessup CJ; Cox GM; Perfect JR; Ghannoum MA
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3231-3. PubMed ID: 11600388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
    El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
    BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Colorimetric broth microdilution for antifungal susceptibility testing].
    Yamane N; Tosaka M; Okazawa Y
    Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activities and cytotoxicity studies of six new azasordarins.
    Herreros E; Almela MJ; Lozano S; Gomez de las Heras F; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
    Fleck R; Dietz A; Hof H
    J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.
    Johnson EM; Ojwang JO; Szekely A; Wallace TL; Warnock DW
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1412-6. PubMed ID: 9624486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.
    Yardley V; Croft SL
    Int J Antimicrob Agents; 2000 Feb; 13(4):243-8. PubMed ID: 10755238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.